Title : Soy isoflavones reduce asthma exacerbation in asthmatic patients with high PAI-1-producing genotypes.

Pub. Date : 2019 Jul

PMID : 30707970






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Soy isoflavones reduce asthma exacerbation in asthmatic patients with high PAI-1-producing genotypes. Isoflavones serpin family E member 1 Homo sapiens
2 Previous studies suggest that soy isoflavones can reduce PAI-1 levels. Isoflavones serpin family E member 1 Homo sapiens
3 OBJECTIVE: We sought to investigate PAI-1 genotype-specific differences of the soy isoflavone response in asthma outcomes. Isoflavones serpin family E member 1 Homo sapiens
4 METHODS: A PAI-1 functional polymorphism (rs1799768, 4G5G) was characterized in subjects with poorly controlled asthma enrolled in a randomized clinical trial of soy isoflavones (n = 265). Isoflavones serpin family E member 1 Homo sapiens
5 Soy isoflavones reduced plasma PAI-1 levels compared with placebo. Isoflavones serpin family E member 1 Homo sapiens
6 CONCLUSIONS: This study demonstrates that soy isoflavone treatment provides a significant benefit in reducing the number of severe asthma exacerbations in asthmatic patients with the high PAI-1-producing genotype. Isoflavones serpin family E member 1 Homo sapiens
7 PAI-1 polymorphisms can be used as a genetic biomarker for soy isoflavone-responsive patients with asthma. Isoflavones serpin family E member 1 Homo sapiens